GL1X · GenesisL1 explorer

MolNFT v1 · #100764 · protein

Crystal structure of the VPS10P domain of human SORTILIN/NTS3 in complex with AF38469

4N7E: “Crystal structure of the VPS10P domain of human SORTILIN/NTS3 in complex with AF38469”. X-ray diffraction, 3 ligands (2JQ, NAG, BMA), 6 pockets (best druggability 0.64). MolNFT v1 #100764 on GenesisL1: 3D structure, binding sites…

PDB
4N7E
Type
protein
Length
653 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Sortilin
UniProt
Q99523
Ligands
2JQ, NAG, BMA
Pockets
6 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASortilinprotein6537% helix, 40% strandQ99523

Ligands and binding sites

  • 2JQ · 2-[(6-methylpyridin-2-yl)carbamoyl]-5-(trifluoromethyl)benzoic acid · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • BMA · beta-D-mannopyranose · sugar
  • PGE · Triethylene glycol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15010.640.7769empty
21390.410.7524NAG
3840.410.78152JQ
4530.350.7921PGE
5800.300.7319empty

Modifications

Observed in the structure: 7 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 4N7E · Crystal structure of the Vps10p domain of human sortilin/NTS3 in complex with AF38469 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99523 · AlphaFold monomer V2.0 prediction for sortilin (Q99523) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.